CIK: 0001974915
Total reported value
$3.6B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Stock-Other | 5.39% | +1.13% | +200.00% | |
| 2 | ACLXGBX | Arcellx INC | Stock-Other | 4.63% | -6.48% | EXIT | |
| 3 | NUVL | Nuvalent Inc-a | Stock-Other | 4.30% | +1.22% | +2.33% | |
| 4 | ABVX | Abivax Sa-adr | Stock-Other | 3.83% | -4.04% | — | |
| 5 | ALC | Alcon Inc. | Stock-Healthcare | 3.70% | -1.27% | +109.52% | |
| 6 | BCAX | Bicara Therapeutics INC | Stock-Other | 3.64% | +0.97% | +2.00% | |
| 7 | AM6 | Amicus Therapeutics INC | Stock-Other | 3.47% | — | -18.07% | |
| 8 | GMED | Globus Medical INC - A | Stock-Healthcare | 3.23% | -2.31% | +150.00% | |
| 9 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 3.18% | — | +115.00% | |
| 10 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 2.98% | -1.68% | EXIT | |
| 11 | BDX | Becton Dickinson And Co | Stock-Healthcare | 2.75% | — | +1200.00% | |
| 12 | SRRK | Scholar Rock Holding CORP | Stock-Other | 2.52% | +0.77% | — | |
| 13 | ✓ | Immatics NV | Stock-Other | 2.44% | — | +1.60% | |
| 14 | RGEN | Repligen CORP | Stock-Healthcare | 2.41% | +2.59% | — | |
| 15 | DNTH | Dianthus Therapeutics INC | Stock-Other | 2.10% | — | -63.13% | |
| 16 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.03% | -0.41% | +66.00% | |
| 17 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 1.99% | — | -45.00% | |
| 18 | DXCM | Dexcom INC | Stock-Healthcare | 1.98% | -2.88% | EXIT | |
| 19 | CYTK | Cytokinetics INC | Stock-Healthcare | 1.80% | +0.55% | NEW | |
| 20 | BIIB | Biogen INC | Stock-Healthcare | 1.74% | — | — | |
| 21 | CDTX | Cidara Therapeutics INC | Stock-Other | 1.73% | — | -20.00% | |
| 22 | CATBUSD | Astria Therapeutics INC | Stock-Other | 1.63% | — | +9.60% | |
| 23 | DYN | Dyne Therapeutics INC | Stock-Other | 1.59% | +1.95% | +281.44% | |
| 24 | TYRA | Tyra Biosciences INC | Stock-Other | 1.53% | -2.11% | -8.66% | |
| 25 | ABT | Abbott Laboratories | Stock-Healthcare | 1.51% | -2.56% | EXIT | |
| 26 | IRON | Disc Medicine INC | Stock-Other | 1.49% | — | +257.14% | |
| 27 | NRIX | Nurix Therapeutics INC | Stock-Other | 1.45% | — | +73.75% | |
| 28 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.41% | — | -50.00% | |
| 29 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.41% | — | -31.14% | |
| 30 | ZYME | Zymeworks INC | Stock-Other | 1.36% | -0.77% | EXIT | |
| 31 | DHR | Danaher CORP | Stock-Healthcare | 1.34% | — | +200.00% | |
| 32 | RVMD | Revolution Medicines INC | Stock-Healthcare | 1.33% | +5.66% | -47.50% | |
| 33 | RAPP | Rapport Therapeutics INC | Stock-Other | 1.27% | — | — | |
| 34 | ELVN | Enliven Therapeutics INC | Stock-Other | 1.07% | +1.55% | +364.00% | |
| 35 | GERN | Geron CORP | Stock-Other | 1.07% | — | -27.55% | |
| 36 | BLTE | Belite Bio INC - Adr | Stock-Other | 1.04% | — | — | |
| 37 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.02% | — | — | |
| 38 | VERA | Vera Therapeutics INC | Stock-Other | 1.00% | +0.59% | -75.48% | |
| 39 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.97% | — | +0.68% | |
| 40 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.95% | — | -0.89% | |
| 41 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.85% | -1.65% | EXIT | |
| 42 | SLDB | Solid Biosciences INC | Stock-Other | 0.83% | — | +97.67% | |
| 43 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.82% | -1.30% | EXIT | |
| 44 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.81% | — | +83.33% | |
| 45 | APGE | Apogee Therapeutics INC | Stock-Other | 0.76% | +1.18% | — | |
| 46 | SVRA | Savara INC | Stock-Other | 0.65% | — | -63.55% | |
| 47 | BRKR | Bruker CORP | Stock-Healthcare | 0.65% | — | -12.00% | |
| 48 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.63% | +0.86% | NEW | |
| 49 | QURE | uniQure N.V. | Stock-Other | 0.59% | — | -93.92% | |
| 50 | BBNX | Beta Bionics INC | Stock-Other | 0.54% | — | +9.09% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | +3.7% | +200.00% | Add |
| 2 | GMED | Globus Medical INC - A | +2.2% | +150.00% | Add |
| 3 | CLDX | Celldex Therapeutics INC | +1.2% | -31.14% | Add |
| 4 | BCAX | Bicara Therapeutics INC | +1.1% | +2.00% | Add |
| 5 | AM6 | Amicus Therapeutics INC | +1% | -18.07% | Add |
| 6 | CDTX | Cidara Therapeutics INC | +1% | -20.00% | Trim |
| 7 | ZYME | Zymeworks INC | +0.9% | +53.48% | Add |
| 8 | LXEO | Lexeo Therapeutics INC | +0.7% | +0.68% | Add |
| 9 | NRIX | Nurix Therapeutics INC | +0.5% | +73.75% | Add |
| 10 | DYN | Dyne Therapeutics INC | +0.3% | +281.44% | Add |
| 11 | ✓ | Immatics NV | +0.1% | +1.60% | Trim |
| 12 | CATBUSD | Astria Therapeutics INC | 0% | +9.60% | Add |
| 13 | DNTH | Dianthus Therapeutics INC | -0.1% | -63.13% | Trim |
| 14 | SRRK | Scholar Rock Holding CORP | -0.5% | — | Add |
| 15 | ✓ | Establishment Labs Hldgs INC | -1.1% | — | Trim |
| 16 | NUVL | Nuvalent Inc-a | -1.1% | +2.33% | Add |
| 17 | SVRA | Savara INC | -1.5% | -63.55% | Trim |
| 18 | CRNX | Crinetics Pharmaceuticals In | -2.2% | -50.00% | Trim |
| 19 | QURE | uniQure N.V. | -3% | -93.92% | Trim |
| 20 | VERA | Vera Therapeutics INC | -3.3% | -75.48% | Trim |
| 21 | 4XC1 | Kalvista Pharmaceuticals INC | -3.5% | -83.96% | Trim |
| 22 | CYTK | Cytokinetics INC | -5.6% | -75.63% | Trim |
| 23 | ACLXGBX | Arcellx INC | -6.6% | -54.55% | Trim |
| 24 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 25 | INSM | Insmed INC | — | EXIT | Sold out |
| 26 | ALC | Alcon Inc. | — | NEW | New buy |
| 27 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 28 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | New buy |
| 29 | BDX | Becton Dickinson And Co | — | NEW | New buy |
| 30 | RGEN | Repligen CORP | — | NEW | New buy |
| 31 | BMRN | Biomarin Pharmaceutical INC | — | NEW | New buy |
| 32 | DXCM | Dexcom INC | — | NEW | New buy |
| 33 | BIIB | Biogen INC | — | NEW | New buy |
| 34 | ABT | Abbott Laboratories | — | NEW | New buy |
| 35 | IRON | Disc Medicine INC | — | NEW | New buy |
| 36 | GPCR | Structure Therapeutics INC | — | EXIT | Sold out |
| 37 | RVMD | Revolution Medicines INC | — | NEW | New buy |
| 38 | RAPP | Rapport Therapeutics INC | — | NEW | New buy |
| 39 | URGN | UroGen Pharma Ltd. | — | EXIT | Sold out |
| 40 | ELVN | Enliven Therapeutics INC | — | NEW | New buy |
| 41 | BLTE | Belite Bio INC - Adr | — | NEW | New buy |
| 42 | AXSM | Axsome Therapeutics INC | — | NEW | New buy |
| 43 | LQDA | Liquidia CORP | — | EXIT | Sold out |
| 44 | TSHA | Taysha Gene Therapies INC | — | NEW | New buy |
| 45 | COGT | Cogent Biosciences INC | — | EXIT | Sold out |
| 46 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |
| 47 | APGE | Apogee Therapeutics INC | — | NEW | New buy |
| 48 | PRGO | Perrigo Company plc | — | EXIT | Sold out |
| 49 | GEHC | GE Healthcare Technology | — | EXIT | Sold out |
| 50 | REGN | Regeneron Pharmaceuticals | — | NEW | New buy |